Paper25567367
Population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers.
An G and 5 others. AAPS J, 2015. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers. Papers, record 25567367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25567367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium Channel Blockers | Major topic |
| Heterocyclic Compounds, 2-Ring | Major topic |
| Models, Biological | Major topic |
| Sulfonamides | Major topic |
| Uric Acid | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Computer Simulation | |
| Dose-Response Relationship, Drug | |
| Double-Blind Method | |
| Female | |
| Gout | |
| Humans | |
| Male | |
| Middle Aged | |
| Sex Factors | |
| Young Adult | |
| Benzenesulfonamides |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 25676842 | Erratum to: population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers. | https://conductscience.org/library/papers/25676842 |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24726441 | A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats. | Biochem Pharmacol | 2014 | https://conductscience.org/library/papers/24726441 | PubMed |
| 2 | 11177768 | Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient. | Curr Rheumatol Rep | 2001 | https://conductscience.org/library/papers/11177768 | PubMed |
| 3 | 12024214 | Molecular identification of a renal urate anion exchanger that regulates blood urate levels. | Nature | 2002 | https://conductscience.org/library/papers/12024214 | PubMed |
| 4 | 1027698 | Current therapy of gout and hyperuricemia. | Hosp Pract | 1976 | https://conductscience.org/library/papers/1027698 | PubMed |
| 5 | 6691361 | Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. | Am J Med | 1984 | https://conductscience.org/library/papers/6691361 | PubMed |
| 6 | 8552148 | The management of gout. | N Engl J Med | 1996 | https://conductscience.org/library/papers/8552148 | PubMed |
| 9 | 9849314 | Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout. | Ann Rheum Dis | 1998 | https://conductscience.org/library/papers/9849314 | PubMed |
| 10 | 15919000 | Renal urate handling: clinical relevance of recent advances. | Curr Rheumatol Rep | 2005 | https://conductscience.org/library/papers/15919000 | PubMed |
| 11 | 21800283 | Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. | Arthritis Rheum | 2011 | https://conductscience.org/library/papers/21800283 | PubMed |
| 12 | 19692116 | Gout. | Lancet | 2010 | https://conductscience.org/library/papers/19692116 | PubMed |
| 13 | 18729537 | Febuxostat. | Drugs | 2008 | https://conductscience.org/library/papers/18729537 | PubMed |
| 14 | 17278930 | New insights into renal transport of urate. | Curr Opin Rheumatol | 2007 | https://conductscience.org/library/papers/17278930 | PubMed |
| 15 | 16707532 | EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). | Ann Rheum Dis | 2006 | https://conductscience.org/library/papers/16707532 | PubMed |
| 16 | 16820043 | Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. | Arthritis Res Ther | 2006 | https://conductscience.org/library/papers/16820043 | PubMed |
| 17 | 16339094 | Febuxostat compared with allopurinol in patients with hyperuricemia and gout. | N Engl J Med | 2005 | https://conductscience.org/library/papers/16339094 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42515693 | Population Pharmacokinetic Analysis and Modelling of Serum Uric Acid Dynamics in Patients Treated with Favipiravir. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515693 | PubMed |
| 41340907 | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effects of Single and Multiple Oral Doses of ABP-671 in Healthy and Hyperuricemic Subjects. | Drug Des Devel Ther | 2025 | https://conductscience.org/library/papers/41340907 | PubMed |
| 33110473 | Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/33110473 | PubMed |
| 31977576 | The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. | J Hypertens | 2020 | https://conductscience.org/library/papers/31977576 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLC22A12 | 116085 | PubTator's text mining | https://conductscience.org/library/genes/116085 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25567367
GET https://conductscience.org/api/papers/v1/25567367/authors